The paucity of therapeutic choices is a reality often acknowledged by the US Food and Drug Administration (FDA) as it reviews applications for new medical …
Dates: August 09-10, 2018 Location: Philadelphia, PA Positive patient experiences lead to successful clinical trials with high adherence and high participation rates. The pharmaceutical industry’s …
Basic brain and behavioral researchers will get more than a year to comply with a new U.S. policy that will treat many of their studies …
NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, announced today that it is launching …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
